“The acquisition of TopazIS appears to be a well-timed move by NextGen Healthcare,” said Aaron Gleave, Clinical Research Director for KLAS Research, a leading healthcare research firm. “NextGen Healthcare is acquiring additional technology as the market is beginning to accelerate the adoption of technology platforms and solutions in this space. Behavioral Health has been an underserved area, and we’d love to see NextGen Healthcare deliver the same level of excellence that we’ve observed in its ambulatory offerings the past couple years.”
The NextGen Behavioral health Suite specializes in ensuring that organization have easy access to true and collaborative healthcare. By focusing on the use of technology, there has been results that proven solution provides automation, pervasive interoperability, and superior analytics-driven medical and behavioral health workflows and is supported by a team with true subject matter expertise. This helps to increase the level of productivity in clinical practice in the long run.
“The importance of effectively treating behavioral and mental health has appropriately garnered national attention,” said Rusty Frantz, President and Chief Executive Officer of NextGen Healthcare. “The large majority of Americans understand that mental health is just as important as physical health. With the Topaz acquisition, NextGen is doubling down on our commitment to the behavioral health specialty for both societal and business benefits. We strongly believe companies do well by doing good.”
“Topaz has been a proud NextGen Healthcare partner since 2000,” said Javier Favela, formerly TopazIS Chief Executive Officer and now Vice President, Behavioral Health Solutions at NextGen Healthcare. “Because our cultures, technologies and missions were already so well aligned, it made perfect sense to join forces. We couldn’t be more delighted to become part of NextGen Healthcare, a company that truly cares about its providers and their clients.”